Tan Jiachang, Li Yuping, Wu Zhenjie, Zhao Jinmin
Department of Bone and Soft Tissue Surgery, Affiliated Tumor Hospital, Guangxi Medical University, Nanning 530021, People's Republic of China.
The First Clinical Medical College, Guangxi Medical University, Nanning 530021, People's Republic of China.
Ther Clin Risk Manag. 2018 Sep 24;14:1747-1755. doi: 10.2147/TCRM.S171970. eCollection 2018.
We aimed to conduct a meta-analysis of published cohort studies to evaluate the risk of hip fracture in patients undergoing dialysis or kidney transplantation (KT).
We identified relevant studies by searching PubMed, EMBASE and Google Scholar databases from their inception to December 31, 2017. Cohort studies evaluating risk of hip fractures in patients undergoing dialysis or KT were considered included. The methodological quality of the cohort studies was assessed using the modified Newcastle-Ottawa scale.
In our meta-analysis of 14 retrospective cohort studies, a total of more than 1.5 million patients undergoing dialysis or KT were included, of whom more than 30,000 had hip fractures. After the merger, the proportion of hip fractures was 1.92% (95% CI, 1.38%-2.46%) with significant heterogeneity ( =99.9%, =0.000) in all patients, and the incidence rate of hip fractures (per 1,000 person-years) was 8.95 (95% CI, 4.05-13.85) with significant heterogeneity ( =99.9%, =0.000). The pooled relative risks (RR) value for dialysis patients compared with the general population were 6.35 (95% CI, 4.53-8.88) for male and 5.57 (95% CI, 4.44-6.99) for female. The pooled RR value for hemodialysis (HD) patients compared with peritoneal dialysis (PD) patients was 1.39 (95% CI, 1.13-1.70) with no heterogeneity ( =0.0%, =0.763).
In conclusion, the present meta-analysis reveals that about 2% of dialysis or KT patients go on to sustain a hip fracture during follow-up, with the overall hip fracture incidence rates being 8.95 per 1,000 person-years. The overall risk of hip fracture was more than 5-fold higher in dialysis patients than in the general population. Among patients on PD, HD, and KT, HD and KT patients had the highest and the lowest risk of hip fractures, respectively.
我们旨在对已发表的队列研究进行荟萃分析,以评估接受透析或肾移植(KT)的患者发生髋部骨折的风险。
我们通过检索PubMed、EMBASE和谷歌学术数据库,从其创建到2017年12月31日,确定相关研究。评估接受透析或KT的患者髋部骨折风险的队列研究被纳入。使用改良的纽卡斯尔-渥太华量表评估队列研究的方法学质量。
在我们对14项回顾性队列研究的荟萃分析中,总共纳入了超过150万接受透析或KT的患者,其中超过30000人发生了髋部骨折。合并后,所有患者中髋部骨折的比例为1.92%(95%可信区间,1.38%-2.46%),存在显著异质性(I² = 99.9%,P = 0.000),髋部骨折的发病率(每1000人年)为8.95(95%可信区间,4.05 - 13.85),存在显著异质性(I² = 99.9%,P = 0.000)。与普通人群相比,透析患者的合并相对风险(RR)值男性为6.35(95%可信区间,4.53 - 8.88),女性为5.57(95%可信区间,4.44 - 6.99)。与腹膜透析(PD)患者相比,血液透析(HD)患者的合并RR值为1.39(95%可信区间,1.13 - 1.70),无异质性(I² = 0.0%,P = 0.763)。
总之,本荟萃分析表明,约2%的透析或KT患者在随访期间会发生髋部骨折,总体髋部骨折发病率为每1000人年8.95例。透析患者髋部骨折的总体风险比普通人群高5倍以上。在接受PD、HD和KT的患者中,HD和KT患者发生髋部骨折的风险分别最高和最低。